These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19236369)

  • 1. Response to Barraclough et al. on 'degree-of-spread artefact in the NSW Central Cancer Registry'.
    Yu XQ; O'Connell D; Armstrong B
    Aust N Z J Public Health; 2009 Feb; 33(1):95-6. PubMed ID: 19236369
    [No Abstract]   [Full Text] [Related]  

  • 2. Degree-of-spread artefact in the New South Wales Central Cancer Registry.
    Barraclough H; Morrell S; Arcorace M; McElroy HJ; Baker DF
    Aust N Z J Public Health; 2008 Oct; 32(5):414-6. PubMed ID: 18959542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?
    Tracey E; Roder D; Luke C; Bishop J
    BJU Int; 2009 Aug; 104(4):498-504. PubMed ID: 19338538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 'Catch Up' Plan for radiotherapy in New South Wales to 2012.
    Morgan G; Barton M; Crossing S; Bull C; Penman A
    J Med Imaging Radiat Oncol; 2009 Aug; 53(4):419-30. PubMed ID: 19695050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inequalities in breast cancer stage at diagnosis in the Trent region, and implications for the NHS Breast Screening Programme.
    Cuthbertson SA; Goyder EC; Poole J
    J Public Health (Oxf); 2009 Sep; 31(3):398-405. PubMed ID: 19423544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis using life tables of the major causes of death and the differences between country of birth groups in New South Wales, Australia.
    Weerasinghe DP; Parr NJ; Yusuf F
    Public Health; 2009 May; 123(5):351-7. PubMed ID: 19443003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methodologic and organizational problems of establishing a State Cancer Registry].
    Merabishvili VM; Starinskiĭ VV
    Vopr Onkol; 1998; 44(2):233-7. PubMed ID: 9615835
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cancer Registry reporting can be improved].
    Klint A; Talbäck M; Holmberg L
    Lakartidningen; 2009 Mar 11-17; 106(11):752-3. PubMed ID: 19418794
    [No Abstract]   [Full Text] [Related]  

  • 9. The National Joint Registry may fail to collect accurate, validated anaesthetic data.
    Howes BW; Clarke PA; Cook TM
    Anaesthesia; 2009 Jun; 64(6):694-5. PubMed ID: 19453336
    [No Abstract]   [Full Text] [Related]  

  • 10. THE NEW SOUTH WALES GYNAECOLOGICAL CANCER REGISTRY.
    MCGARRITY KA
    Med J Aust; 1964 Aug; 2():190-1. PubMed ID: 14176481
    [No Abstract]   [Full Text] [Related]  

  • 11. [Trophoblastic tumor registry of the German Gynecological Oncology Working Group (AGO)].
    Horn LC; Vogel M; Schmidt D; Ulrich U;
    Pathologe; 2009 Jul; 30(4):324-5. PubMed ID: 19513715
    [No Abstract]   [Full Text] [Related]  

  • 12. Case report: Mississippi's new central cancer registry design and implementation.
    Penman AD; Brackin BT; Moulder JT
    J Miss State Med Assoc; 1996 Apr; 37(4):537-9. PubMed ID: 8935636
    [No Abstract]   [Full Text] [Related]  

  • 13. Regional tumor registry benefits physicians, patients.
    Decker LH
    Tex Hosp; 1987 Aug; 43(3):26, 37. PubMed ID: 10283671
    [No Abstract]   [Full Text] [Related]  

  • 14. Justifying registry operations.
    Webb MA
    J Registry Manag; 2010; 37(1):35-6. PubMed ID: 20795571
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged.
    Tang YC; Thoman M; Linton PJ; Deisseroth A
    Cancer Immunol Immunother; 2009 Dec; 58(12):1949-57. PubMed ID: 19444444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database.
    Petri AL; Kjaer SK; Christensen IJ; Blaakaer J; Hogdall E; Jeppesen U; Mosgaard BJ; Pagel JD; Stilling L; Thranov I; Hogdall C
    Acta Obstet Gynecol Scand; 2009; 88(5):536-42. PubMed ID: 19308749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of data collected in the Danish Veterinary Cancer Registry.
    Brønden LB; Lindstrand S; Nielsen SS; Toft N; Kristensen AT
    Vet Comp Oncol; 2009 Sep; 7(3):207-11. PubMed ID: 19691649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death.
    Michaelson JS; Chen LL; Silverstein MJ; Cheongsiatmoy JA; Mihm MC; Sober AJ; Tanabe KK; Smith BL; Younger J
    Cancer; 2009 Nov; 115(21):5084-94. PubMed ID: 19670457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Another opportunity for prevention: assessing alcohol use by women attending breast screening services in Lismore, NSW.
    Daly MD; Passey ME; Harvey AJ
    N S W Public Health Bull; 2009; 20(5-6):90-2. PubMed ID: 19552856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic assessment of central cancer registry operations. Part II: developing and testing a cost assessment tool.
    Subramanian S; Tangka F; Green J; Weir H; Michaud F
    J Registry Manag; 2009; 36(2):47-52. PubMed ID: 19694117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.